AU2001284188A1 - Thiazolidine derivatives and its use as antifungal agent - Google Patents
Thiazolidine derivatives and its use as antifungal agentInfo
- Publication number
- AU2001284188A1 AU2001284188A1 AU2001284188A AU8418801A AU2001284188A1 AU 2001284188 A1 AU2001284188 A1 AU 2001284188A1 AU 2001284188 A AU2001284188 A AU 2001284188A AU 8418801 A AU8418801 A AU 8418801A AU 2001284188 A1 AU2001284188 A1 AU 2001284188A1
- Authority
- AU
- Australia
- Prior art keywords
- antifungal agent
- thiazolidine derivatives
- nr3r4
- thiazolidine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940121375 antifungal agent Drugs 0.000 title 1
- 239000003429 antifungal agent Substances 0.000 title 1
- 150000003548 thiazolidines Chemical class 0.000 title 1
- 101100516568 Caenorhabditis elegans nhr-7 gene Proteins 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0021419 | 2000-08-31 | ||
| GBGB0021419.7A GB0021419D0 (en) | 2000-08-31 | 2000-08-31 | Compounds |
| PCT/GB2001/003860 WO2002022612A1 (en) | 2000-08-31 | 2001-08-30 | Thiazolidine derivatives and its use as antifungal agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001284188A1 true AU2001284188A1 (en) | 2002-03-26 |
Family
ID=9898614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001284188A Abandoned AU2001284188A1 (en) | 2000-08-31 | 2001-08-30 | Thiazolidine derivatives and its use as antifungal agent |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6740670B2 (enExample) |
| EP (1) | EP1313731B1 (enExample) |
| JP (1) | JP2004509121A (enExample) |
| AT (1) | ATE482954T1 (enExample) |
| AU (1) | AU2001284188A1 (enExample) |
| DE (1) | DE60143165D1 (enExample) |
| ES (1) | ES2353685T3 (enExample) |
| GB (1) | GB0021419D0 (enExample) |
| WO (1) | WO2002022612A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS53252B (sr) | 2003-08-11 | 2014-08-29 | F.Hoffmann-La Roche Ag. | Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1 |
| HRP20110694T1 (hr) | 2004-03-15 | 2011-12-31 | Janssen Pharmaceutica Nv | Novi spojevi kao modulatori opioidnog receptora |
| CN101072762B (zh) | 2004-12-09 | 2010-06-23 | 弗·哈夫曼-拉罗切有限公司 | 苯基-哌嗪甲酮衍生物 |
| BRPI0519054A2 (pt) | 2004-12-15 | 2008-12-23 | Hoffmann La Roche | fenil metanonas bi e tricÍclicas substituÍdas como inibidores de transportador i de glicina (glyt-1) para o tratamento de doenÇa de alzheimer |
| US7485637B2 (en) | 2005-01-04 | 2009-02-03 | Hoffmann-La Roche Inc. | Benzoyl-tetrahydropiperidine derivatives |
| DE602005022113D1 (de) | 2005-01-07 | 2010-08-12 | Hoffmann La Roche | Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen |
| BRPI0606730A2 (pt) | 2005-01-18 | 2009-07-14 | Hoffmann La Roche | derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos |
| ATE447572T1 (de) | 2005-01-26 | 2009-11-15 | Hoffmann La Roche | Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer |
| HRP20100076T1 (hr) | 2005-02-07 | 2010-03-31 | F. Hoffmann - La Roche Ag | Heterociklički supstituirani fenil metanoni kao inhibitori glicin transportera 1 |
| JP5411929B2 (ja) | 2008-05-20 | 2014-02-12 | メルク・シャープ・アンド・ドーム・コーポレーション | マンノシルトランスフェラーゼ阻害剤を使用した異種蛋白質の効率的生産 |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| RU2662153C1 (ru) * | 2017-04-20 | 2018-07-24 | Общество С Ограниченной Ответственностью "Дермавитал Групп" | Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение |
| RU2690161C1 (ru) * | 2018-06-28 | 2019-05-31 | Общество С Ограниченной Ответственностью "Дермавитал Групп" | 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью |
| RU2703997C1 (ru) * | 2018-12-13 | 2019-10-23 | Общество с ограниченной ответственностью "Л-Био" | Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью |
| US11292776B2 (en) | 2019-12-12 | 2022-04-05 | University Of Sharjah | Small molecule inhibitors of fungal hyphae and biofilm formation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US47109A (en) * | 1865-04-04 | Improvement in governors | ||
| FR1548312A (enExample) * | 1967-06-06 | 1968-12-06 | ||
| JPS5740478A (en) * | 1980-08-22 | 1982-03-06 | Ono Pharmaceut Co Ltd | Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative |
| DE4318550A1 (de) * | 1993-06-04 | 1994-12-08 | Boehringer Mannheim Gmbh | Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19835316A1 (de) * | 1998-08-05 | 2000-02-10 | Bosch Gmbh Robert | Gesteuerte Gleichrichterbrücke mit Überspannungsschutz |
| AU6330799A (en) * | 1998-09-30 | 2000-04-17 | Roche Diagnostics Gmbh | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
-
2000
- 2000-08-31 GB GBGB0021419.7A patent/GB0021419D0/en not_active Ceased
-
2001
- 2001-08-30 ES ES01963155T patent/ES2353685T3/es not_active Expired - Lifetime
- 2001-08-30 DE DE60143165T patent/DE60143165D1/de not_active Expired - Lifetime
- 2001-08-30 AU AU2001284188A patent/AU2001284188A1/en not_active Abandoned
- 2001-08-30 EP EP01963155A patent/EP1313731B1/en not_active Expired - Lifetime
- 2001-08-30 JP JP2002526865A patent/JP2004509121A/ja active Pending
- 2001-08-30 WO PCT/GB2001/003860 patent/WO2002022612A1/en not_active Ceased
- 2001-08-30 AT AT01963155T patent/ATE482954T1/de active
-
2003
- 2003-02-21 US US10/371,979 patent/US6740670B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2353685T3 (es) | 2011-03-04 |
| GB0021419D0 (en) | 2000-10-18 |
| WO2002022612A1 (en) | 2002-03-21 |
| JP2004509121A (ja) | 2004-03-25 |
| US20030216453A1 (en) | 2003-11-20 |
| WO2002022612A8 (en) | 2002-05-23 |
| ATE482954T1 (de) | 2010-10-15 |
| US6740670B2 (en) | 2004-05-25 |
| EP1313731A1 (en) | 2003-05-28 |
| DE60143165D1 (de) | 2010-11-11 |
| EP1313731B1 (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001284188A1 (en) | Thiazolidine derivatives and its use as antifungal agent | |
| WO2002076995A3 (en) | 2-amino-propanol derivatives | |
| AU2001284190A1 (en) | Benzylidene thiazolidinediones and their use as antimycotic agents | |
| DK0423714T3 (da) | Hårrevitaliseringsmiddel | |
| DK109487A (da) | Fungicid paa basis af et cyanopyrrolderivat | |
| PT1078923E (pt) | Processo para a preparacao de derivados de benzotiofeno | |
| MXPA02012046A (es) | Composicion limpiadora a base de biocida. | |
| WO2004063330A3 (en) | (2-carboxamido) (3-amino) thiophene compounds | |
| SE0004245D0 (sv) | Novel compounds and their use | |
| PT96664A (pt) | Processo para a preparacao de derivados neuroprotectores de 3-piperidino-4-hidroxicromano | |
| ATE368645T1 (de) | Aminosäurederivate als hiv-protease-inhibitoren | |
| AU2001262401A1 (en) | Use of ellagic acid as anti-pollution cosmetic agent | |
| KR920017655A (ko) | 상처의 치료를 촉진시키기 위한 약학 조성물 | |
| AU8062487A (en) | New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents | |
| AU9678501A (en) | Pharmaceutical solutions of modafinil compounds | |
| SI0843967T1 (en) | Use of Beta-aminopropionic acid derivatives as fungicides | |
| ATE250610T1 (de) | Kaliumkanal-blockierende mittel | |
| ATE317263T1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
| DE3665584D1 (de) | Spiro-imidazolidines as aldose reductase inhibitors | |
| BR0009453B1 (pt) | processo para a preparação de um composto. | |
| AU3565700A (en) | Antibacterial agents | |
| EP1207166A3 (en) | Process for the preparation of 6.alpha.-fluoro,9,11.beta.-epoxy-steroids | |
| CA2434408A1 (en) | Process for the preparation of heterocyclic indene analogs | |
| CA2421008A1 (en) | Substituted heterocyclic compounds for treating multidrug resistance | |
| UY26416A1 (es) | Compuestos |